Greater Cannabis Company (GCAN) Free Cash Flow (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Free Cash Flow of -$4376.0 in Q1 2026, up 81.87% quarter-over-quarter from -$24140.0 in Q4 2025, and up 60.77% on a YoY basis from -$2721.9 in Q1 2025.
Greater Cannabis Company (GCAN) Free Cash Flow (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$4376.0 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 60.77% year-over-year to -$4376.0; the TTM figure through Mar 2026 stood at -$53374.0 (up 35.78% YoY), while the FY2025 annual figure was -$60153.0, up 45.06% from the prior year.
- Free Cash Flow was -$4376.0 for Q1 2026 at Greater Cannabis Company, up from -$24140.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$4376.0 in Q1 2026 to a low of -$56392.0 in Q2 2022.
- Historically, Free Cash Flow has averaged -$22628.3 across 5 years, with a median of -$19064.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow jumped 84.96% in 2024, then plunged 391.25% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$19064.0 in 2022, then tumbled by 71.39% to -$32673.0 in 2023, then surged by 84.96% to -$4914.0 in 2024, then tumbled by 391.25% to -$24140.0 in 2025, then soared by 81.87% to -$4376.0 in 2026.
- The last three Free Cash Flow figures came in at -$4376.0 (Q1 2026), -$24140.0 (Q4 2025), and -$5357.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Greater Cannabis Company | - | - | - | -4,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,376.00 |
| Mar 31, 2026 | -4,376.00 |
| Dec 31, 2025 | -24,140.00 |
| Dec 31, 2025 | -24,140.00 |
| Sep 30, 2025 | -5,357.00 |
| Sep 30, 2025 | -5,357.00 |
| Jun 30, 2025 | -19,501.00 |
| Jun 30, 2025 | -19,501.00 |
| Mar 31, 2025 | -11,155.00 |
| Mar 31, 2025 | -11,155.00 |
| Dec 31, 2024 | -4,914.00 |
| Dec 31, 2024 | -4,914.00 |
| Sep 30, 2024 | -18,034.00 |
| Sep 30, 2024 | -18,034.00 |
| Jun 30, 2024 | -49,007.00 |
| Jun 30, 2024 | -49,007.00 |
| Mar 31, 2024 | -37,536.00 |
| Mar 31, 2024 | -37,536.00 |
| Dec 31, 2023 | -32,673.00 |
| Dec 31, 2023 | -32,673.00 |